• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美吲哚洛尔在慢性肾衰竭患者中的药代动力学

Pharmacokinetics of mepindolol in patients with chronic renal failure.

作者信息

Krause W, Kampf D, Fischer H C

出版信息

Eur J Clin Pharmacol. 1984;27(4):429-33. doi: 10.1007/BF00549590.

DOI:10.1007/BF00549590
PMID:6519149
Abstract

Five patients with a creatinine clearance of 14 to 37 ml/min/1.73 m2 were each given an oral dose of 10 mg of the beta-blocker mepindolol sulphate (Corindolan). In addition, two dialysis patients received the same dose either during hemodialysis or on a dialysis-free day. Plasma levels of mepindolol were measured by a sensitive, specific HPLC method. Mepindolol was rapidly absorbed in all the patients. The maximum plasma level of 35 +/- 8 ng/ml was reached after 1.4 +/- 0.5 h. The half-life of disposition was 4.0 +/- 1.5 h. The area under the plasma concentration-time curve was 237 +/- 84 ng X h/ml. The data obtained were no different from those found in normal healthy volunteers.

摘要

五名肌酐清除率为14至37毫升/分钟/1.73平方米的患者分别口服了10毫克β受体阻滞剂硫酸美品洛尔(Corindolan)。此外,两名透析患者在血液透析期间或非透析日接受了相同剂量。采用灵敏、特异的高效液相色谱法测定美品洛尔的血浆水平。美品洛尔在所有患者中均迅速吸收。1.4±0.5小时后达到最大血浆水平35±8纳克/毫升。处置半衰期为4.0±1.5小时。血浆浓度-时间曲线下面积为237±84纳克·小时/毫升。获得的数据与正常健康志愿者的数据无差异。

相似文献

1
Pharmacokinetics of mepindolol in patients with chronic renal failure.美吲哚洛尔在慢性肾衰竭患者中的药代动力学
Eur J Clin Pharmacol. 1984;27(4):429-33. doi: 10.1007/BF00549590.
2
Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.健康志愿者口服硫酸美吡哒后血浆中美吡哒的水平。
Arzneimittelforschung. 1983;33(9):1306-7.
3
Pharmacokinetics of mepindolol administered alone and in combination with hydrochlorothiazide--a bioequivalence study.美哌洛尔单独及与氢氯噻嗪联合给药的药代动力学——一项生物等效性研究。
Biopharm Drug Dispos. 1983 Oct-Dec;4(4):339-45. doi: 10.1002/bdd.2510040406.
4
Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses.单次及每日重复给药后,母乳喂养母亲将美哌洛尔传递给新生儿的情况。
Eur J Clin Pharmacol. 1982;22(1):53-5. doi: 10.1007/BF00606425.
5
Determination of plasma mepindolol levels by high-performance liquid chromatography and electrochemical detection.采用高效液相色谱法和电化学检测法测定血浆美吲哚洛尔水平。
J Chromatogr. 1980 Jan 11;181(1):67-75. doi: 10.1016/s0378-4347(00)81270-0.
6
Pharmacokinetics and pharmacodynamics of mepindolol sulphate.硫酸美吲哚洛尔的药代动力学与药效学
Int J Clin Pharmacol Ther Toxicol. 1980 Apr;18(4):169-76.
7
Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.慢性肾衰竭患者和健康志愿者单次口服他林洛尔后的药代动力学及稳态药代动力学
Int J Clin Pharmacol Ther. 2001 Feb;39(2):61-6. doi: 10.5414/cpp39061.
8
Metabolism of pindolol in patients with renal failure.肾衰竭患者中吲哚洛尔的代谢
Eur J Clin Pharmacol. 1982;22(5):423-8. doi: 10.1007/BF00542547.
9
Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.霉酚酸酯在终末期肾衰竭患者中的药代动力学。
Kidney Int. 2000 Mar;57(3):1164-8. doi: 10.1046/j.1523-1755.2000.00943.x.
10
The effect of hemodialysis on piperacillin pharmacokinetics.血液透析对哌拉西林药代动力学的影响。
Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):680-4.

引用本文的文献

1
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒:EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.

本文引用的文献

1
Sotalol kinetics in renal insufficiency.
Clin Pharmacol Ther. 1981 Apr;29(4):457-63. doi: 10.1038/clpt.1981.63.
2
Propranolol disposition in renal failure.肾衰竭时普萘洛尔的处置
Br J Clin Pharmacol. 1980 Dec;10(6):561-6. doi: 10.1111/j.1365-2125.1980.tb00511.x.
3
Pharmacokinetics of atenolol in relation to renal function.阿替洛尔的药代动力学与肾功能的关系。
Eur J Clin Pharmacol. 1981 Jan;19(1):65-71. doi: 10.1007/BF00558387.
4
Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.
Eur J Clin Pharmacol. 1980 Oct;18(4):321-6. doi: 10.1007/BF00561389.
5
Atenolol kinetics in renal failure.阿替洛尔在肾衰竭中的动力学
Clin Pharmacol Ther. 1980 Sep;28(3):302-9. doi: 10.1038/clpt.1980.166.
6
Determination of plasma mepindolol levels by high-performance liquid chromatography and electrochemical detection.采用高效液相色谱法和电化学检测法测定血浆美吲哚洛尔水平。
J Chromatogr. 1980 Jan 11;181(1):67-75. doi: 10.1016/s0378-4347(00)81270-0.
7
The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
Clin Pharmacokinet. 1980 Mar-Apr;5(2):192-8. doi: 10.2165/00003088-198005020-00006.
8
Metabolism of pindolol in patients with renal failure.肾衰竭患者中吲哚洛尔的代谢
Eur J Clin Pharmacol. 1982;22(5):423-8. doi: 10.1007/BF00542547.
9
Uremia and the liver. II. Drugs and the liver in the uremic patient.尿毒症与肝脏。II. 尿毒症患者的药物与肝脏
Nephron. 1981;29(1-2):7-13. doi: 10.1159/000182230.
10
Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.肾功能损害患者中醋丁洛尔及其乙酰代谢物的血浆和尿液浓度。
N Z Med J. 1980 Apr 23;91(658):289-91.